Pharmacokinetics of an oral frusemide/amiloride combination tablet.

Abstract:

:A randomized four-way crossover study was carried out in 12 healthy volunteers to investigate the pharmacokinetics of a new oral combination of frusemide (40 mg) and amiloride (5 mg), formulated as a single tablet. The experimental design of this bioequivalence study used commercially-available 40 mg frusemide tablets and 5 mg amiloride tablets as reference drugs, administered either separately or concomitantly. From a statistical analysis of plasma levels of frusemide and amiloride, no significant differences between the reference drugs alone and the combination tablet were seen in peak plasma levels, mean times to peak or mean areas under the plasma concentration-time curves (AUCs). The ratio of AUCs of the combination tablet to the reference drugs approached a limiting value many hours prior to complete elimination of the drug and hence reliable bioavailability comparisons were possible with blood sampling up to 24 hours post-dose.

journal_name

Curr Med Res Opin

authors

Brooks SG,Christie RB,Roche J,Fairhead AP,Muirhead D,Townsend HA,Shaw HL

doi

10.1185/03007998409109572

subject

Has Abstract

pub_date

1984-01-01 00:00:00

pages

141-6

issue

2

eissn

0300-7995

issn

1473-4877

journal_volume

9

pub_type

临床试验,杂志文章,随机对照试验
  • Modelling the economic and health consequences of cardiac resynchronization therapy in the UK.

    abstract:OBJECTIVE:Clinical evidence supports the use of cardiac resynchronization therapy (CRT) in advanced heart failure, but its cost-effectiveness is still unclear. This analysis assessed the economic and health consequences in the UK of implanting a CRT in patients with NYHA class III-IV heart failure. METHODS:A discrete ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079906X112516

    authors: Caro JJ,Guo S,Ward A,Chalil S,Malik F,Leyva F

    更新日期:2006-06-01 00:00:00

  • Recombinant luteinizing hormone supplementation to recombinant follicle stimulating hormone therapy in gonadotropin releasing hormone analogue cycles: what is the evidence?

    abstract:OBJECTIVE:To look into current evidence exploring the added value of rLH supplementation to rFSH in GnRH analogues cycles, to identify groups of women that still have no evidence for adjuvant rLH therapy and to discuss ways that may advance research on this topic. METHODS:Eight systematic reviews and meta-analyses exp...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2017.1417827

    authors: Younis JS,Laufer N

    更新日期:2018-05-01 00:00:00

  • Real-world evidence of the safety and efficacy profile of suvorexant in elderly patients with insomnia: a sub-analysis of the post-marketing drug-use results survey in Japan.

    abstract::Objective: Global Phase III trials of suvorexant showed no obvious differences in the safety and efficacy profile of suvorexant between elderly and non-elderly patients. However, the clinical profile of suvorexant in elderly patients with comorbidities in a real-world setting was not evaluated. To further understand t...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2019.1700361

    authors: Takeuchi Y,Sano H,Asai Y,Miyazaki M,Iwakura M,Maeda Y

    更新日期:2020-03-01 00:00:00

  • Double-blind parallel study of a combination of chlorthalidone 50 mg and triamterene 50 mg in patients with mild and moderate hypertension.

    abstract::In a double-blind, partial cross-over study of 141 patients with mild to moderate hypertension, chlorthalidone 50 mg was compared with chlorthalidone 50 mg/triamterene 50 mg combination treatment. The study assessed clinical efficacy in the reduction of blood pressure, and safety with regard to serum potassium concent...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章

    doi:10.1185/03007999609111560

    authors: Spiers DR,Wade RC

    更新日期:1996-01-01 00:00:00

  • Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patients.

    abstract:BACKGROUND:Patients with chronic myeloid leukemia (CML) who do not adhere to treatment may experience suboptimal outcomes. OBJECTIVE:To examine the association between adherence with imatinib and direct healthcare costs and resource utilization in a large group of privately insured CML patients. PATIENTS AND METHODS:...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007990903396469

    authors: Wu EQ,Johnson S,Beaulieu N,Arana M,Bollu V,Guo A,Coombs J,Feng W,Cortes J

    更新日期:2010-01-01 00:00:00

  • A comprehensive review of the role of the hedgehog pathway and vismodegib in the management of basal cell carcinoma.

    abstract:BACKGROUND:Basal cell carcinoma (BCC) is the most common cancer. Most cases of BCCs are treated with only optimal surgical resection. However, unresectable, locally advanced or metastatic tumors might have potential to progress. In this patient group, there is no standardized treatment approach. Vismodegib is a new sel...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007995.2015.1018988

    authors: Erdem GU,Sendur MA,Ozdemir NY,Yazıcı O,Zengin N

    更新日期:2015-04-01 00:00:00

  • Neurogenic bladder and disc disease: a brief review.

    abstract:OBJECTIVE:Neurogenic bladder refers to morphofunctional alterations of the bladder-sphincter complex secondary to central or peripheral neurological lesions. Discal etiology can be suggested by clinical observation in patients complaining of classical lower back pain, but not excluded even without musculoskeletal pain....

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007995.2013.807788

    authors: Siracusa G,Sparacino A,Lentini VL

    更新日期:2013-08-01 00:00:00

  • An overview and commentary on retrospective, continuous glucose monitoring for the optimisation of care for people with diabetes.

    abstract:INTRODUCTION:Normoglycaemia in people with diabetes results in improved outcome. Continuous glucose monitoring provides detailed diagnostic information used to optimise therapy with the goal of achieving normoglycaemia. The objective of this study was to review the published literature evaluating the single device avai...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007990903094452

    authors: Currie CJ,Poole CD,Papo NL

    更新日期:2009-10-01 00:00:00

  • Achieving glycemic goal with initial versus sequential combination therapy using metformin and pioglitazone in type 2 diabetes mellitus.

    abstract:OBJECTIVE:To compare glycemic goal achievement (HbA(1c) < 7%) in type 2 diabetes patients receiving initial metformin plus pioglitazone combination therapy and initial metformin monotherapy augmented with pioglitazone in a cohort follow-up study. RESEARCH DESIGN AND METHODS:Adult patients were identified from the Inge...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2010.536755

    authors: Pandya BJ,Bron M,McCall T,Yu AP,Chen KS,Mattson ME,Wu EQ

    更新日期:2011-01-01 00:00:00

  • The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.

    abstract:OBJECTIVE:It has been acknowledged that patients who receive a beta-blocker or diuretic based regimen are at increased risk of developing new-onset diabetes. Recently, angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) have been shown to decrease patients' odds of developing new-o...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,meta分析

    doi:10.1185/030079907X188044

    authors: Kuti EL,Baker WL,White CM

    更新日期:2007-06-01 00:00:00

  • Post hoc analysis of the Cluster Randomized Usual Care versus Caduet Investigation Assessing Long-term risk (CRUCIAL) trial.

    abstract:OBJECTIVE:A proactive, multifactorial intervention strategy incorporating single-pill amlodipine/atorvastatin (SPAA) (5-10/10 mg up-titrated to 5-10/20 mg, where approved) is more effective than physician's usual care (UC) for reducing calculated 10 year coronary heart disease (CHD) risk, in patients with hypertension ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,随机对照试验

    doi:10.1185/03007995.2013.783795

    authors: Hradec J,Zamorano J,Sutradhar S

    更新日期:2013-06-01 00:00:00

  • Effects of pirazolac on arachidonic acid metabolism in the human synovial system.

    abstract::Six patients suffering from rheumatoid arthritis with massive knee joint effusions were treated with single daily doses of 600 mg pirazolac, a novel non-steroidal anti-inflammatory drug, for 3 days. Before the first dose, 3 hours after the second and the third dose, specimens of plasma and synovial fluid were drawn si...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007998709112409

    authors: Kurowski M,Dunky A,Geddawi M

    更新日期:1987-01-01 00:00:00

  • Evaluation of an isotonic tear in combination with topical cyclosporine for the treatment of ocular surface disease.

    abstract:PURPOSE:To determine whether a new category of artificial tear product, carboxymethylcellulose 0.5% with compatible solutes (CMC-solutes) (Optive, Allergan, Inc., Irvine, California) improves clinical outcomes when used adjunctively with topical cyclosporine 0.05% (Restasis, Allergan, Inc., Irvine, California) for the ...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章

    doi:10.1185/030079907X219670

    authors: Hardten DR,Brown MJ,Pham-Vang S

    更新日期:2007-09-01 00:00:00

  • A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with allopurinol, celecoxib and cimetidine in healthy subjects.

    abstract:OBJECTIVE:Aliskiren is the first in a new class of orally effective direct renin inhibitors approved for the treatment of hypertension. This multiple-dose study investigated the potential for pharmacokinetic interactions between aliskiren and three drugs, each predominantly eliminated by a different clearance/metabolic...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章

    doi:10.1185/030079908X260934

    authors: Ayalasomayajula S,Tchaloyan S,Yeh CM,Bizot MN,Dieterich HA,Howard D,Dole WP

    更新日期:2008-03-01 00:00:00

  • Mycophenolic acid trough level monitoring in solid organ transplant recipients treated with mycophenolate mofetil: association with clinical outcome.

    abstract:BACKGROUND:Mycophenolate mofetil (MMF) is widely and successfully used in immunosuppressive regimens for the prophylaxis of organ rejection following transplantation. Conventionally, it is administered at a fixed dose without serial measurements of plasma concentrations of mycophenolic acid (MPA), the active metabolite...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/030079906X148481

    authors: Kaplan B

    更新日期:2006-12-01 00:00:00

  • Pathfinding to an optimal strategy of revascularization in primary coronary intervention in patients with multivessel disease: a network meta-analysis of randomized trials.

    abstract:OBJECTIVES:In ST-segment elevation myocardial infarction (STEMI), current guidelines discourage treatment of the non-culprit lesions at the time of the primary intervention. Latest trials have challenged this strategy suggesting benefit of early complete revascularization. We performed a Bayesian multiple treatment net...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2016.1260534

    authors: Komócsi A,Kehl D,d'Ascenso F,DiNicolantonio J,Vorobcsuk A

    更新日期:2017-03-01 00:00:00

  • Medication nonfulfillment rates and reasons: narrative systematic review.

    abstract:BACKGROUND:The literature on nonfulfillment of prescription medications spans over three decades of work. There is a wide variation in reported nonfulfillment rates, but no previous study has systematically reviewed this literature to explore the reasons behind this variation. OBJECTIVE:The objective of this study was...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007990903550586

    authors: Gadkari AS,McHorney CA

    更新日期:2010-03-01 00:00:00

  • Undertreatment of hypercholesterolemia.

    abstract::Abstract Recent guidelines recommend strict goals for low-density lipoprotein cholesterol (LDL-C) (1.8-2.6 mmol/L; 70-100 mg/dL). However, these goals are not always met and many primary and secondary prevention patients are not optimally controlled. Both the under-prescription of lipid-lowering medication and lack of...

    journal_title:Current medical research and opinion

    pub_type: 评论,社论

    doi:10.1185/03007990903512396

    authors: Daskalopoulou SS,Doonan RJ,Mikhailidis DP

    更新日期:2010-02-01 00:00:00

  • Development of a family functioning scale for major depressive disorder.

    abstract:OBJECTIVE:To better understand depression's impact on family functioning from the perspectives of patients with major depressive disorder (MDD) and their partners; to develop and test patient and partner versions of a new self-reported measure, the Depression and Family Functioning Scale (DFFS), for use in clinical tri...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007995.2012.658910

    authors: DiBenedetti DB,Danchenko N,François C,Lewis S,Davis KH,Fehnel SE

    更新日期:2012-03-01 00:00:00

  • Comparison of temazepam 7.5 mg with temazepam 15 mg for the treatment of transient insomnia.

    abstract:OBJECTIVE:To demonstrate the equivalent efficacy of temazepam 7.5 mg and temazepam 15 mg for the treatment of transient insomnia. RESEARCH DESIGN AND METHODS:This was a double-blind, parallel group, multicenter study. Healthy male and female subjects with previous but not current complaints of transient insomnia were ...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1185/030079904125003151

    authors: Erman MK,Loewy D,Scharf MB

    更新日期:2004-04-01 00:00:00

  • Treatment patterns and symptom control in patients with GERD: US community-based survey.

    abstract:BACKGROUND:Proton pump inhibitors (PPIs) are the most commonly used pharmacological treatment for gastroesophageal reflux disease (GERD). OBJECTIVE:To examine the utilization patterns of PPIs and other GERD-related medications, satisfaction with PPI treatment and presence of GERD symptoms. PATIENTS AND METHODS:GERD p...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007990903035745

    authors: Chey WD,Mody RR,Wu EQ,Chen L,Kothari S,Persson B,Beaulieu N,Lu M

    更新日期:2009-08-01 00:00:00

  • Anti-anxiety agents: duration of use and characteristics of users in the U.S.A.

    abstract::A national survey of psychotherapeutic drug use was carried out in the U.S.A. in 1979. Data were obtained from a probability sample (n = 3161) of adults in the general population, using a clinically-oriented interview lasting an average of 90 minutes. The data provide estimates of the prevalence of using anxiolytic an...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007998409109542

    authors: Mellinger GD,Balter MB,Uhlenhuth EH

    更新日期:1984-01-01 00:00:00

  • The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trials.

    abstract:OBJECTIVE:To determine the ability of statins to prevent the development of new-onset type 2 diabetes mellitus through a meta-analysis of randomized, controlled trials. RESEARCH DESIGN AND METHODS:A systematic literature search through November 6, 2007 was conducted to identify randomized, placebo-controlled trials of...

    journal_title:Current medical research and opinion

    pub_type: 信件,评审

    doi:10.1185/030079908x292029

    authors: Coleman CI,Reinhart K,Kluger J,White CM

    更新日期:2008-05-01 00:00:00

  • A year-long quality improvement project on fluid management using blood volume monitoring during hemodialysis.

    abstract:BACKGROUND:Inadequate removal of extracellular volume markedly increases blood pressure and contributes to high morbidity and mortality in hemodialysis patients. Advances in fluid management are needed to improve clinical outcomes. The aim of this quality improvement project was to examine the advantages of using a hem...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2015.1047746

    authors: Balter P,Ficociello LH,Taylor PB,Usvyat L,Sawin DA,Mullon C,Diaz-Buxo J,Zabetakis P

    更新日期:2015-01-01 00:00:00

  • Lifitegrast clinical efficacy for treatment of signs and symptoms of dry eye disease across three randomized controlled trials.

    abstract:OBJECTIVE:Report efficacy findings from three clinical trials (one phase 2 and two phase 3 [OPUS-1, OPUS-2]) of lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease (DED). RESEARCH DESIGN AND METHODS:Three 84-day, randomized, double-masked, placebo-controlled trials. Adults (≥18 years) with DED were r...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2016.1210107

    authors: Holland EJ,Whitley WO,Sall K,Lane SS,Raychaudhuri A,Zhang SY,Shojaei A

    更新日期:2016-10-01 00:00:00

  • The impact on utilities of differences in body weight among Canadian patients with type 2 diabetes.

    abstract:OBJECTIVE:The objective of this study was to estimate utility values for hypothetical health states that describe differences in weight and quality of life associated with type 2 diabetes mellitus (DM) from Canadians with type 2 DM. The impact on utility values was examined separately for participants with a body mass ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2014.899207

    authors: Lane S,Levy AR,Mukherjee J,Sambrook J,Tildesley H

    更新日期:2014-07-01 00:00:00

  • Incidence of second primary malignancies in patients with esophageal cancer: a comprehensive review.

    abstract:BACKGROUND:Development of a second primary malignancy (SPM) after an index esophageal cancer is fairly rare, primarily due to decreased survival in patients with esophageal cancer. However, with advances in early detection and therapy, the number of long-term survivors is increasing, as is the incidence of SPMs in this...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007995.2013.816276

    authors: Nandy N,Dasanu CA

    更新日期:2013-09-01 00:00:00

  • Current approaches for prophylactic cranial irradiation in extrapulmonary small cell carcinoma.

    abstract:BACKGROUND:Small cell lung cancer (SCLC) patients, who have achieved complete or partial response after chemotherapy, should be followed with prophylactic cranial irradiation (PCI). PCI for extrapulmonary small cell carcinoma (EPSCC) is not routinely recommended. The purpose of this review is to discuss all aspects of ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007995.2014.904771

    authors: Yazıcı O,Ozdemir NY,Sendur MA,Aksoy S,Zengin N

    更新日期:2014-07-01 00:00:00

  • Six-day clotrimazole therapy in vaginal candidosis.

    abstract::Two hundred and two patients with symptoms, signs and mycological evidence of Candida vaginitis were entered in a single-blind trial comparing 6-day clotrimazole therapy with a control group receiving 6 days' nystatin therapy. Adequate data was collected on 69 clotrimazole and 72 nystatin treated patients for analysis...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007997509113652

    authors: Masterton G,Henderson J,Napier IR,Moffet M

    更新日期:1975-01-01 00:00:00

  • Effect of the novel oral dipeptidyl peptidase IV inhibitor vildagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.

    abstract:OBJECTIVE:Vildagliptin is a potent and selective dipeptidyl peptidase-IV (DPP-4) inhibitor that improves glycemic control in patients with type 2 diabetes by increasing alpha and beta-cell responsiveness to glucose. This study assessed the effect of multiple doses of vildagliptin 100 mg once daily on warfarin pharmacok...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,随机对照试验

    doi:10.1185/030079907x188008

    authors: He YL,Sabo R,Riviere GJ,Sunkara G,Leon S,Ligueros-Saylan M,Rosenberg M,Dole WP,Howard D

    更新日期:2007-05-01 00:00:00